Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Head and Neck Cancer

Free Subscription 29.06.2026 1 Am J Surg 11 BMC Cancer 1 BMC Surg 2 Clin Cancer Res 3 Dis Esophagus 2 Head Neck 1 Int J Cancer 4 Int J Radiat Oncol Biol Phys 2 J Clin Oncol 1 Laryngoscope 3 Oral Oncol 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg

1. MILAN M, Thomas SM, Terry J, Frieze TW, et al
   Should patient age be incorporated into Oncocytic thyroid carcinoma staging? Evidence from SEER and NCDB.
   Am J Surg. 2026;260:117105.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. WU M, Fang J, Zhang T
   The expression and clinical significance of IL-27 and Foxp3 in oral squamous cell carcinoma.
   BMC Cancer. 2025;25:1199.
   PubMed         Abstract available
   
   
3. DONDERS DNV, Heldens GTN, Tellman RS, Takes RP, et al
   Magnetic sentinel lymph node detection using superparamagnetic iron oxide in early-stage oral squamous cell carcinoma: design and rationale of the multicenter magnetics trial - study protocol.
   BMC Cancer. 2025;25:1539.
   PubMed         Abstract available
   
   
4. WU L, Pan C, Wang W, Gao Y, et al
   Peripheral circulating proteomic profiling reveals serum CD80 is positively correlated with the efficacy of neoadjuvant PD-1 blockade combined with chemotherapy for esophagus cancer.
   BMC Cancer. 2025;25:1608.
   PubMed         Abstract available
   
   
5. WANG Y, Yu F, Qiu F, Fang K, et al
   Global burden of respiratory system cancers in 2022 and 2050: incidence and mortality estimates from GLOBOCAN.
   BMC Cancer. 2025;25:1832.
   PubMed         Abstract available
   
   
6. LIU Y, Sun R, Liu J, Li Q, et al
   Identification and validation of key biomarkers for chemoresistance in oral squamous cell carcinoma.
   BMC Cancer. 2025;26:67.
   PubMed         Abstract available
   
   
7. UDEABOR SE, Ishfaq M, Shah SJ, Khalid I, et al
   Discovery of novel FGFR1 inhibitors for oral squamous cell carcinoma using a multi-class QSAR model, virtual screening, and molecular dynamics simulations.
   BMC Cancer. 2025;26:146.
   PubMed         Abstract available
   
   
8. LI H, Chen Y, Guo G, Luo Q, et al
   PPP4C: a potential molecular marker and therapeutic target in thyroid cancer and triple-negative breast cancer.
   BMC Cancer. 2026 May 4. doi: 10.1186/s12885-026-16083.
   PubMed         Abstract available
   
   
9. KAPOOR A, Gupta A, Sansar B, Mishra BK, et al
   Immuno-oncology in the perioperative setting: the next frontier in resectable head and neck cancers - a systematic review.
   BMC Cancer. 2026 Jun 26. doi: 10.1186/s12885-026-16304.
   PubMed         Abstract available
   
   
10. CAI Y, Wei N, Zhang J, Lin R, et al
    Prognostic significance of pretreatment pan-immune inflammation value in esophageal squamous cell carcinoma patients undergoing definitive chemoradiotherapy.
    BMC Cancer. 2026 Jun 26. doi: 10.1186/s12885-026-16369.
    PubMed         Abstract available
    
    
11. YOU T, Huan F, Luo Z, Ma Y, et al
    Machine learning-powered audio-omics processing method as an auxiliary diagnostic approach for advanced nasopharyngeal carcinoma.
    BMC Cancer. 2026 Jun 24. doi: 10.1186/s12885-026-16374.
    PubMed         Abstract available
    
    
12. LUO M, Zhu D, Yin X
    Sanguinarine as a multi-target therapeutic candidate for laryngeal cancer: insights from network pharmacology, molecular dynamics and in vitro validation.
    BMC Cancer. 2026 Jun 20. doi: 10.1186/s12885-026-16377.
    PubMed         Abstract available
    
    

    
    BMC Surg

13. GAO Q, Wei Y, Fan X, Xu W, et al
    Delayed tracheal injury following total thyroidectomy: case report and literature review.
    BMC Surg. 2025;25:556.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

14. ZAMULKO O, Nusbaum S, Osterburg A, Crist M, et al
    A Phase 2 Feasibility Study Combining Pembrolizumab and Metformin in patients with Metastatic Head and Neck Cancer.
    Clin Cancer Res. 2026 Jun 25. doi: 10.1158/1078-0432.CCR-26-0874.
    PubMed         Abstract available
    
    
15. VUJANOVIC L, Torres-Saavedra P, Tu F, Uppaluri R, et al
    Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma.
    Clin Cancer Res. 2026 Jun 25:10.1158/1078-0432.CCR-25-4796.
    PubMed         Abstract available
    
    

    
    Dis Esophagus

16. CAMMAROTA A, Puccini A, Jones CM, van Rossum PSN, et al
    Circulating tumour DNA in oligometastatic oesophago-gastric cancers: applications, challenges, and future directions.
    Dis Esophagus. 2026;39:doag059.
    PubMed         Abstract available
    
    
17. ABE T, An B, Higaki E, Hosoi T, et al
    Lessons learned from routine thoracic duct visualization using high-fat ice cream during esophagectomy: insights from long-term clinical practice.
    Dis Esophagus. 2026;39:doag060.
    PubMed         Abstract available
    
    
18. FOUAD M, Sourial K, Ibraheim S
    Impact of omental flap reinforcement on anastomotic leak after esophagectomy: updated evidence incorporating minimally invasive and high-volume contemporary series.
    Dis Esophagus. 2026;39:doag061.
    PubMed         Abstract available
    
    

    
    Head Neck

19. TIAN J, Li Y, Wang Z, Jiang K, et al
    Clinicopathological Characteristics and Prognostic Significance of RET Fusion in Papillary Thyroid Carcinoma.
    Head Neck. 2026 Jun 25. doi: 10.1002/hed.70369.
    PubMed         Abstract available
    
    
20. LIU V, Martinez J, Yip HT, Wang SJ, et al
    Non-Invasive Approaches to Internal Lymphedema in Head and Neck Cancer Survivors: A Scoping Review.
    Head Neck. 2026 Jun 25. doi: 10.1002/hed.70374.
    PubMed         Abstract available
    
    

    
    Int J Cancer

21. ZHU X, Zhang X, Liu J, Li Z, et al
    Clinical Value of Patient-Derived Tumor Organoids in Guiding Precision Chemotherapy for Locally Advanced Thyroid Cancer: A Single-Center, Single-Arm, Phase 2 Trial.
    Int J Cancer. 2026;159:836-843.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

22. OSBOURNE G, Devlin A, Walsh N, Hardcastle N, et al
    Radiation Therapy Target Objectives for Tonsillar Cancer Treated With Unilateral Radiation Therapy-A Replanning Study From TROG 12.01.
    Int J Radiat Oncol Biol Phys. 2026;125:1051-1058.
    PubMed         Abstract available
    
    
23. CAUDELL JJ, Echevarria M, Yang G, Kim Y, et al
    Phase 2 Prospective Trial of Personalized Radiation Therapy Fractionation in Human Papillomavirus Positive Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2026;125:1043-1050.
    PubMed         Abstract available
    
    
24. COSPER PF, Paracha M, Jones KM, Hrycyniak L, et al
    Pretreatment Chromosomal Instability Correlates With Radiation Sensitivity in Squamous Cell Cancers.
    Int J Radiat Oncol Biol Phys. 2026;125:1176-1189.
    PubMed         Abstract available
    
    
25. HANSEN CR, Tadic T, Sharma M, Price G, et al
    Global Dose Prescription Variances Exemplified Through Oropharynx Cancer: When Is 70 Gray 70 Gray?
    Int J Radiat Oncol Biol Phys. 2026;125:1252-1257.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

26. TAHARA M, Kiyota N, Kodaira T, Nishino H, et al
    Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck Cancer.
    J Clin Oncol. 2026 Jun 26:JCO2501708. doi: 10.1200/JCO-25-01708.
    PubMed         Abstract available
    
    
27. FANG R, Lei W, Huang B, Chen L, et al
    Retraction: Neoadjuvant Adebrelimab Plus Chemotherapy in Untreated Locally Advanced Head and Neck Squamous Cell Carcinoma: Efficacy and Biomarker Insights From a Single-Arm Phase II Trial.
    J Clin Oncol. 2026 Jun 26:JCO2601525. doi: 10.1200/JCO-26-01525.
    PubMed        
    
    

    
    Laryngoscope

28. CLEMENTS AC, Pan C, Bhatt NK, Roth M, et al
    Thyroid Cartilage Reconstruction With Titanium Mesh in Advanced Papillary Thyroid Carcinoma.
    Laryngoscope. 2026 Jun 23. doi: 10.1002/lary.70695.
    PubMed         Abstract available
    
    

    
    Oral Oncol

29. TOPKAN E, Selek U
    Evaluation of a quasi-automatic treatment planning workflow for head-and-neck cancer in radiotherapy.
    Oral Oncol. 2026;180:108059.
    PubMed        
    
    
30. HONG MH, Lee S, Kim CG, Son W, et al
    Corrigendum to "A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma" [Oral Oncol. 170 (2025) 107745].
    Oral Oncol. 2026 Jun 20:108052. doi: 10.1016/j.oraloncology.2026.108052.
    PubMed        
    
    
31. LYU Y, Chen L, Cen X, Deng Y, et al
    The survival benefit of postoperative radiotherapy in pN1 head and neck squamous cell carcinoma without adverse pathological features: analysis of the SEER database.
    Oral Oncol. 2026;180:108055.
    PubMed         Abstract available
    
    

    
    PLoS One

32. LIU Q, Yin Y, Hu G, Li H, et al
    Downregulation of SLC44A4 in nasopharyngeal carcinoma is associated with malignant progression, B-cell/TLS-related immune features, and sensitivity to DNA-damaging agents.
    PLoS One. 2026;21:e0352812.
    PubMed         Abstract available
    
    
33. BALUTA L, Humbert M, Babin E, Morello R, et al
    Innovative screening for OSAS in patients with head and neck cancer using the apneal application: Protocol for a prospective single-centre study.
    PLoS One. 2026;21:e0346607.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum